Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Date:11/6/2009

ontains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including our ability to raise additional funds or enter strategic alliances, advance development of our potential products and complete research and development, including pre-clinical and clinical studies, the continuation of arrangements with our product development partners and customers, competition, government regulation and approvals, and general economic conditions. For example, we may not obtain regulatory approval for our products, which would materially impair our ability to generate revenue. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission. Such filings are available on our website or at www.sec.gov. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances.

    Contacts:
    Investor Relations
    info@scolr.com
    SCOLR Pharma, Inc.
    425-368-1050 ext 1080

                                SCOLR Pharma, Inc.

                             CONDENSED BALANCE SHEETS
                                   (Unaudited)

                                              September 30
'/>"/>
SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
4. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
7. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
8. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
9. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
10. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Calif. , April 16, 2015  Amgen (NASDAQ: ... its first quarter financial results on Tuesday, April 21, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... , April 16, 2015  Rosewind Corporation (OTCMKTS: ... reverse merger with a newly formed specialty healthcare ... focus on addressing urological disorders. The merged company, ... Inc., has commenced operations and incorporates the pipeline ... The Company,s strategy is to build a late-stage ...
Breaking Medicine Technology:Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Calif., Dec. 19, 2011 Pharmacyclics, Inc. (Nasdaq: ... on developing and commercializing innovative small molecule drugs ... diseases, announced today issue notification from the United ... ) of a patent entitled "Inhibitors of Bruton,s ...
... 2011    , ... Gerresheimer invests around EUR 25 million in its ...   Gerresheimer AG, one of the world,s ... the growth market of complex plastic systems for pharmaceutical and medical ...
Cached Medicine Technology:Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent 2Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent 3Gerresheimer Extends Production of Medical Plastic Systems in Bavaria 2
(Date:4/19/2015)... Carinsuranceshoppingsource.com has released a new blog post ... cheap auto insurance plan . , Motorcycles can ... covered under cheap auto insurance plans. Insurance brokers have ... models are also cheaper to insure. , The ... influence on the auto insurance plan that he/she will ...
(Date:4/19/2015)... has released a new blog post explaining that ... DUI. The blog post also discusses the implications medication ... Some pills can have dangerous side effects that hinder ... medication should ask their doctor’s advice before driving. Being ... driving under the influence and clients can get arrested. ...
(Date:4/19/2015)... A live auction will be held to sell over 4,800 ... NY and other national consignors. Various types of equipment will ... much more. , The auction will take place Tuesday, ... each day. The equipment is at their Chicago warehouse located ... Anyone can participate in the auction including those who cannot ...
(Date:4/18/2015)... For some people, tattoos are works of ... rest of their lives, as they have spent a great ... a great amount of thought on their designs. For others, ... them or simply want them removed for personal or professional ... and in 2012-13 there was a 43 percent increase in ...
(Date:4/18/2015)... Carinsurancehints.com has released a new blog post explaining ... financial protection against fire damage. , Clients can now ... their vehicle is set intentionally on fire. This type of ... by other things. , It is possible to compare ... http://www.carinsurancehints.com/ , in just a few minutes. Clients ...
Breaking Medicine News(10 mins):Health News:Buying Auto Insurance for Motorcycles - Models That Are Cheap to Cover! 2Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Centurion to Sell Surplus Medical Equipment in Online and On-Site Auction 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Online Auto Insurance Quotes For Plans That Cover Fire Damages! 2
... 25, 2011) -- A child,s taste preferences begin at home ... say, young kids learn quickly what brands deliver the goods. ... involving two separate experiments, researchers found that salt, sugar and ... children already could equate their taste preferences to brand-name fast-food ...
... HealthDay Reporter , MONDAY, Jan. 24 (HealthDay News) -- ... therapy may reduce the risk of heart attack, stroke and ... About 30 percent of heart attacks may be linked to ... problems, such as depression and hostility, the authors note in ...
... , MONDAY, Jan. 24 (HealthDay News) -- ... are not as strong as they think. In ... than strangers do, a new study suggests. ... friends than with strangers. That closeness can lead people ...
... Steven Reinberg HealthDay Reporter , MONDAY, Jan. 24 ... children fight obesity, a new study suggests. Too little ... conditions, but "catch-up" sleep on weekends and holidays can mitigate ... the United States, the sleep of our children is clearly ...
... Can optimism be ethically problematic? Yes, according to a ... in early-phase cancer trials and suggested that it may ... assume that hope and optimism in the research context ... they reflect a bias," write the authors of the ...
... By Dennis Thompson HealthDay Reporter , SUNDAY, ... of a mainstream approach to Americans, health woes. People ... serenity and wellness, but its roots in ancient Indian philosophy ... alternative medicine. However, a growing body of scientific ...
Cached Medicine News:Health News:Preschool kids know what they like: Salt, sugar and fat 2Health News:Preschool kids know what they like: Salt, sugar and fat 3Health News:Stress-Reduction Therapy May Help Heart Disease Patients 2Health News:Stress-Reduction Therapy May Help Heart Disease Patients 3Health News:Close Relationships Sometimes Mask Poor Communication 2Health News:Insufficient, Irregular Sleep Tied to Kids' Obesity 2Health News:Insufficient, Irregular Sleep Tied to Kids' Obesity 3Health News:Unrealistic optimism appears common in early cancer trials 2Health News:Yoga's Spiritual Balance May Boost Health 2Health News:Yoga's Spiritual Balance May Boost Health 3
... The STart benchtop coagulation analyzers ... electro-mechanical clot detection. This method ... or other optically dense samples ... programmable and preprogrammed assays with ...
... The STA is a fully-automated, coagulation ... and immunological assays in true random ... of sample management offers high throughput ... without the need to interrupt current ...
... The MLA 750 is an ... automated systems. Photometric end point detection ... clean because no electrodes are inserted ... is virtually impossible. The MLA 750 ...
The ACL 9000 together with an extensive test menu and superior technology is backed by high-quality service to keep the lab running efficiently....
Medicine Products: